Estrogen-containing combined hormonal contraceptives are not tied to vascular risk, such as stroke, in women with migraine ...

The FDA has granted marketing authorization to CT-132 for the preventive treatment of episodic migraine in patients aged 18 years and older.

FDA Cleared Nerivio® REN Wearable Offers Non-Drug Treatment Option for Millions of People With Migraine as Young as 8. NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- For millions o ...

Migraine disease affects millions of Americans, but treatments often cause side effects that hinder sufferers' ability to function.

The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive treatment of episodic migraine.

Migraine is the third most common illness in the world, with about 14 percent of the global population experiencing migraine ...

The FDA has accepted for review the sBLA for fremanezumab-vfrm for the prevention of episodic migraine in pediatric patients aged 6 to-17 years weighing at least 45 kg.

Though evidence is mixed, there are some studies that show that feverfew might be helpful for migraine prevention. Discover if this medicinal plant could be more than just a pretty flower.

For the first time in 30 years, a new drug class known as the CGRP-Antagonists (calcitonin gene-related peptide) has emerged. These medications are proving to be highly effective for migraine ...

Holding announced that it has received approval of a New Drug Submission, NDS, from the Health Canada’s Pharmaceutical Drugs ...

Fremanezumab is a calcitonin-gene related peptide (CGRP) pathway monoclonal antibody that is FDA approved for adults with ...

Ashwagandha is a medicinal herb that's been used for centuries to treat a number of ailments. Find out if it can be a useful tool in modern migraine toolkits.